Cognition Therapeutics, Inc.
CGTX • NASDAQ
Cognition Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lisa Ricciardi, with a market cap of $65.2M.
CEOLisa Ricciardi
Next Earnings
Upcoming earnings announcement for Cognition Therapeutics, Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Earnings History
Past 12 earnings reports for Cognition Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.01Est: -$0.07 | +85.7% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.06Est: -$0.08 | +25.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.11Est: -$0.11 | 0.0% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.14Est: -$0.12 | -16.7% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.17Est: -$0.15 | -13.3% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.25Est: -$0.22 | -13.6% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.18Est: -$0.23 | +21.7% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.27Est: -$0.29 | +6.9% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.27Est: -$0.34 | +20.6% | - | — | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.22Est: -$0.24 | +8.3% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.16Est: -$0.19 | +15.8% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.21Est: -$0.17 | -23.5% | - | — | — |